All In Biotech

Free tool

FAERS Monitor: Triesence

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 022048 or its brand name (Triesence, Triamcinolone Acetonide). Reports on generic versions are filed under their own applications.

Reports

24,723

Serious

13,254

54% of reports

Hospitalization

6,291

Death reported

3,176

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective3,844
  • off label use2,908
  • pruritus2,715
  • rash2,561
  • pain2,132
  • fatigue2,036
  • nausea1,946
  • product use in unapproved indication1,748
  • diarrhoea1,707
  • vomiting1,703
  • condition aggravated1,686
  • headache1,626
  • arthralgia1,549
  • dizziness1,439
  • infusion related reaction1,419

Reports by year received

View as table
YearReports
200471
200558
200640
200780
2008116
2009130
2010119
2011178
2012185
2013209
2014260
2015477
2016646
2017816
20181,065
20191,229
20201,486
20211,795
20222,317
20232,750
20243,546
20253,872
20263,278

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,029,436 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
infusion related reactionSignal1,41918.617.723,166
pruritusSignal2,7156.05.811,559
product use in unapproved indicationSignal1,7486.05.87,374
rashSignal2,5615.04.88,370
condition aggravatedSignal1,6864.74.55,014
arthralgiaSignal1,5493.23.02,347
vomitingSignal1,7033.13.02,450
painSignal2,1323.02.82,837
off label useSignal2,9082.82.73,581
drug ineffectiveSignal3,8442.52.43,629
dizzinessSignal1,4392.52.31,270
diarrhoeaSignal1,7072.32.21,223
fatigueSignal2,0362.22.11,426
headacheSignal1,6262.22.11,106
nauseaSignal1,9462.12.01,152

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.